Given the link between inflammation and angiogenesis in VS [22, 33, 34], and the possible potential for augmenting immunotherapy response in VS through anti-VEGF vascular normalization [39], the aforementioned imaging and blood biomarkers of tumour microvasculature could play a role here. This evidence concerns the gene VEGFA and neoplasm.